Rapid Fluid Resolution and Durability With Faricimab in Neovascular Age-Related Macular Degeneration
{{output}}
Importance: In the TENAYA and LUCERNE randomized clinical trials (RCTs), approximately 80% of study participants with treatment-naive neovascular age-related macular degeneration (nAMD) achieved at least every-12-week faricimab d... ...
